Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Zhang, Yao ^a   Gao, Zhongming ^a,b   Wang, Dandan ^a   Zhang, Tongshuai ^a   Sun, Bo ^a   Mu, Lili ^a   Wang, Jinghua ^a   Liu, Yumei ^a   Kong, Qingfei ^a   Liu, Xijun ^a   Zhang, Yue ^a,d   Zhang, Haoqiang ^a   He, Jiqing ^a,b   Li, Hulun ^a   Wang, Guangyou ^a,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c Key Lab of Magnetic Resonance Imaging Device and Technique   (China)

^d Department of Otorhinolaryngology Mudanjiang 2nd People's Hospital   (China)

Author keywords

Cerebral ischemia; CXCR3; IP 10; NK cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; ACETYLSALICYLIC ACID; ADRENALIN; ALBUMIN; BICARBONATE; CEFOXITIN; CEPHALOSPORIN; CIMETIDINE; CITICOLINE; DEXAMETHASONE; DEXTRAN; DOPAMINE; FUROSEMIDE; GLUCOSE; GLYCEROL; INSULIN; LOBELINE; MANNITOL; NIMODIPINE; NITROPRUSSIDE SODIUM; NORADRENALIN; OMEPRAZOLE; POTASSIUM CHLORIDE; SALVIA MILTIORRHIZA EXTRACT; SODIUM CHLORIDE; UNINDEXED DRUG; UROKINASE; VALPROIC ACID; CXCR3 PROTEIN, MOUSE; LY ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1 PROTEIN, MOUSE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL MIGRATION; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MALE; MIDDLE AGED; MOUSE; NATURAL KILLER CELL; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADAPTIVE IMMUNITY; BIOACCUMULATION; BLOOD BRAIN BARRIER; BLOOD FLOW; BRAIN HEMORRHAGE; CELL MEMBRANE PERMEABILITY; GENETIC LINKAGE; IMMUNOFLUORESCENCE TEST; INNATE IMMUNITY; MIDDLE CEREBRAL ARTERY OCCLUSION; PROTEIN DEPLETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CELL MOTION; CEREBRAL ARTERY DISEASE; CYTOLOGY; DISEASE MODEL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, LY; APOPTOSIS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL10; DISEASE MODELS, ANIMAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; RECEPTORS, CXCR3;

EID: 84901695614     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-79     Document Type: Article

References (35)

1. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007, 28:138-145. 10.1016/j.it.2007.01.005, 17276138.
2. Wilson DR, Warise L. Cytokines and their role in depression. Perspect Psychiatr Care 2008, 44:285-289. 10.1111/j.1744-6163.2008.00188.x, 18826467.
3. London A, Itskovich E, Benhar I, Kalchenko V, Mack M, Jung S, Schwartz M. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J Exp Med 2011, 208:23-39. 10.1084/jem.20101202, 3023128, 21220455.
4. Madrigal JL, Leza JC, Polak P, Kalinin S, Feinstein DL. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 2009, 29:263-267. 10.1523/JNEUROSCI.4926-08.2009, 19129402.
5. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397. 10.1016/S0166-2236(99)01401-0, 10441299.
6. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006, 66:232-245. 10.1016/j.surneu.2005.12.028, 16935624.
7. Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, Del Zoppo GJ. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994, 144:188-199. 1887114, 8291608.
8. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999, 79:1431-1568.
9. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49. 10.1126/science.1198687, 3089969, 21212348.
10. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990, 76:2421-2438.
11. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640. 10.1016/S1471-4906(01)02060-9, 11698225.
12. Strowig T, Brilot F, Munz C. Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J Immunol 2008, 180:7785-7791. 10.4049/jimmunol.180.12.7785, 2575662, 18523242.
13. Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Regulatory CD56 bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci 2006, 103:5941-5946. 10.1073/pnas.0601335103, 1458677, 16585503.
14. Beum PV, Lindorfer MA, Taylor RP. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving. J Immunol 2008, 181:2916-2924. 10.4049/jimmunol.181.4.2916, 18684983.
15. Yabuhara A, Yang F-C, Nakazawa T, Iwasaki Y, Mori T, Koike K, Kawai H, Komiyama A. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J Rheumatol 1996, 23:171.
16. Peterfalvi A, Molnar T, Banati M, Pusch G, Miko E, Bogar L, Pal J, Szereday L, Illes Z. Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke. Cerebrovasc Dis 2009, 28:490-498. 10.1159/000236527, 19752550.
17. Minematsu K, Li L, Sotak CH, Davis MA, Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 1992, 23:1304-1310. 10.1161/01.STR.23.9.1304, 1519287.
18. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986, 17:1304-1308. 10.1161/01.STR.17.6.1304, 2433817.
19. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13:1173-1175. 10.1038/nm1651, 17828272.
20. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003, 198:725-736. 10.1084/jem.20021098, 2194193, 12939340.
21. Vogelgesang A, Grunwald U, Langner S, Jack R, Broker BM, Kessler C, Dressel A. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 2008, 39:237-241. 10.1161/STROKEAHA.107.493635, 18048864.
22. Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U, Meisel A, Meisel C. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009, 158:1184-1193. 10.1016/j.neuroscience.2008.07.044, 18722511.
23. Urra X, Cervera A, Villamor N, Planas AM, Chamorro A. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 2009, 158:1174-1183. 10.1016/j.neuroscience.2008.06.014, 18619524.
24. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857. 10.1161/STROKEAHA.108.534503, 19265055.
25. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000, 407:802-809. 10.1038/35037739, 11048732.
26. Luster AD, Unkeless JC, Ravetch JV. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985, 315:672-676. 10.1038/315672a0, 3925348.
27. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002, 168:3195-3204. 10.4049/jimmunol.168.7.3195, 11907072.
28. Li HL, Kostulas N, Huang YM, Xiao BG, van der Meide P, Kostulas V, Giedraitas V, Link H. IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat. J Neuroimmunol 2001, 116:5-14. 10.1016/S0165-5728(01)00264-8, 11311324.
29. Chaitanya GV, Eeka P, Munker R, Alexander JS, Babu PP. Role of cytotoxic protease granzyme-b in neuronal degeneration during human stroke. Brain Pathol 2011, 21:16-30. 10.1111/j.1750-3639.2010.00426.x, 20825413.
30. Chaitanya GV, Schwaninger M, Alexander JS, Babu PP. Granzyme-b is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model. Neuroscience 2010, 165:1203-1216. 10.1016/j.neuroscience.2009.10.067, 19895873.
31. Wang X, Ellison JA, Siren AL, Lysko PG, Yue TL, Barone FC, Shatzman A, Feuerstein GZ. Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat. J Neurochem 1998, 71:1194-1204.
32. Wang X, Li X, Schmidt DB, Foley JJ, Barone FC, Ames RS, Sarau HM. Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. Mol Pharmacol 2000, 57:1190-1198.
33. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002, 71:173-183.
34. Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 2013, 36:437-449. 10.1007/s10545-013-9608-0, 23609350.
35. Yang G-Y, Betz AL. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994, 25:1658-1664. 10.1161/01.STR.25.8.1658, 8042219.